Page last updated: 2024-08-23

piperacillin and amikacin

piperacillin has been researched along with amikacin in 237 studies

Research

Studies (237)

TimeframeStudies, this research(%)All Research%
pre-199045 (18.99)18.7374
1990's47 (19.83)18.2507
2000's80 (33.76)29.6817
2010's60 (25.32)24.3611
2020's5 (2.11)2.80

Authors

AuthorsStudies
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J1
Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P1
Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A1
Ariza, J; Dominguez, MA; Gudiol, F; Guzmán, A; Peña, C; Pujol, M; Suarez, C; Tubau, F1
Kamat, V; Sekar, U; Toleman, MA; Vinodh, H; Walsh, TR1
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A1
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C1
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR1
Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Schwaber, MJ1
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R1
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P1
Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM1
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG1
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC1
Lombardo, F; Obach, RS; Waters, NJ1
Bertolini, T; Chow, C; Froelich, JM; Hermann, T; Murphy, DE; Sun, Z; Wall, D; Webber, SE; Zhou, Y1
Carrillo, B; Esparza-Ahumada, S; Garza-Ramos, U; Hernández, E; Jones, RN; Morfin-Otero, R; Rodriguez-Noriega, E; Sader, HS; Sanchez, A; Silva-Sanchez, J1
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Carmeli, Y; Chmelnitsky, I; Navon-Venezia, S; Strahilevitz, J1
Craft, DW; Hachmeister, L; Hong, SG; Kim, SY; Moland, ES; Sayed, SD; Thomson, KS1
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL1
Cattoir, V; Nordmann, P; Poirel, L1
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R1
Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q1
Amicosante, G; De Luca, F; Luzzaro, F; Migliavacca, R; Mugnaioli, C; Pagani, L; Perilli, M; Pini, B; Pollini, S; Rossolini, GM; Spalla, M; Toniolo, A1
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Wickes, BW1
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N1
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C1
Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD1
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD1
Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M1
Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A1
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T1
Campbell, L; Church, DL; Gregson, DB; Laupland, KB; Pitout, JD1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL1
Gales, AC; Nordmann, P; Picão, RC; Poirel, L1
Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U1
Du, X; Ji, S; Jiang, Y; Li, L; Shen, P; Wei, Z; Yu, Y1
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N1
Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L1
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L1
Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM1
Girlich, D; Nordmann, P; Poirel, L1
Ge, Y; Juan, C; Oliver, A; Pérez, JL; Zamorano, L1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Leavitt, A; Navon-Venezia, S; Ofek, I1
Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ1
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ1
Abele-Horn, M; Claus, H; Elias, J; Engelhardt, K; Frosch, M; Joseph, B; Oesterlein, A; Schoen, C; Turnwald, D; Valenza, G1
Jiang, Y; Shen, P; Wei, Z; Yu, D; Yu, Y; Zhou, Z1
Bertrand, X; Dehecq, B; Hocquet, D; Mariotte, P; Plésiat, P; Talon, D1
Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S1
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R1
Chang, FY; Chen, TL; Fung, CP; Hsueh, PR; Ko, WC; Kuo, SC; Lee, YT; Siu, LK1
Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D1
Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D1
George, WL; Lewis, RP; Meyer, RD1
Hanberger, H1
Abbas, Z; Karim, M; Malik, IA1
Fujita, J; Kubo, A; Negayama, K; Takahara, J; Takigawa, K; Yamagishi, Y; Yamaji, Y1
Gentile, G; Girmenia, C; Mandelli, F; Martino, P; Micozzi, A; Raccah, R1
Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P1
Hattori, M; Sampi, K1
Goto, M; Iwayama, N; Izuhara, Y; Kusafuka, H; Maeda, K; Obayashi, T; Sezaki, R; Yoshida, H1
Zhang, YP1
Regnier, B1
Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH1
Ahrne, H; Eilard, T; Eriksson, I; Lausen, I; Maller, R1
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O1
Bialkowska-Hobrzanska, H; Gopaul, D; Hammerberg, O1
Karahan, M; Kiliç, H1
Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ1
Hanberger, H; Isaksson, B; Maller, R; Nilsson, LE; Nilsson, M2
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S1
Crokaert, F; Van der Linden, MP; Yourassowsky, E1
Chanal, C; Chanal, M; Cluzel, M; Joly, B; Sirot, D; Sirot, J1
Matsuo, K; Uete, T1
Blaser, J1
Amstutz, P; Blanloeil, Y; Cathala, B; Chopin, C; Gouin, F; Grimaud, D; Le Gall, JR; Rouby, JJ; Tempe, JD; Vanooteghem-Delbarre, A1
Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M1
De Pauw, B; Donnelly, P; Nováková, I1
Aksebzeci, T; Fazli, SA1
Hammerberg, O; Kurnitzki, C; Rosenbloom, D; Watts, J1
Debbia, EA; Molinari, G; Paglia, P; Pesce, A1
Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G1
Gault, MJ; Gillin, FD; Reiner, DS1
Caillon, J; Drugeon, HB; Juvin, ME; Moinard, D; Pirault, JL1
Amrani, R; Beklahia, C; Labia, R; Morand, A; Verchere-Beaur, C1
Brice, P; Calvo, F; de Castro, H1
Avvisati, G; Fenu, S; Girmena, C; Martino, P; Micozzi, A; Raccah, R; Santilli, S1
Dejace, P; Klastersky, J; Lagast, H; Pascual-Lopez, A1
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T1
Blaser, J; Zinner, SH1
Boelaert, J; Gordts, B; Lambert, A; Van Landuyt, HW1
Belobraydic, KA; Flournoy, DJ; Qadri, SM1
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP1
Andersen, GE; Colding, H; Goldstein, K1
Claeys, G; Van den Abeele, AM; Verschraegen, G1
Boisivon, A; Guiomar, C; Gutmann, L1
Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G1
Munro, R; Rawlinson, W; Sorrell, T1
Ameglio, F; Casali, A; Gallo Curcio, C; Gionfra, T; Paoletti, G; Tonachella, R1
Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B1
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K2
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW1
Sabath, LD; Tack, KJ1
Grassi, C1
Calia, FM; Johnson, DE; Thompson, B1
Benuck, I; Traisman, HS1
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W1
Hattori, M; Kaneko, Y; Kumai, R; Sakurai, M; Sampi, K1
Angel Montañés, M; Apraiz, D; Gamazo, C; Urra, E1
Gale, RP; Hewitt, WL; Ho, WG; Winston, DJ; Young, LS1
Norden, CW; Schafer, F1
Klastersky, J1
Glew, RH; Pavuk, RA1
Hale, DC; Jenkins, R; Matsen, JM1
Mirrett, S; Reimer, LG; Reller, LB1
Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C1
Pickering, LK; Rutherford, I1
Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH1
Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS1
Aronoff, SC; Klinger, JD1
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH1
Chamard-Neuwirth, C; Cordin, X; Duez, JM; Kazmierczak, A; Pechinot, A; Siebor, E2
Calandra, T; Cometta, A; de Bock, R; Gaya, H; Glauser, MP; Klastersky, J; Langenaeken, J; Paesmans, M; Viscoli, C; Zinner, S1
Cony-Makhoul, P; Fière, D; Guy, H; Herbrecht, R; Marie, JP; Milpied, N; Pico, JL; Plantier, I; Vekhoff, A1
Sanders, CV1
Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M1
Gerçeker, AA; Gürler, B1
Biard, O; Casassus, P; Guillevin, L; Lortholary, O; Padoin, C; Petitjean, O; Rizzo, N; Tod, M1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y1
Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C1
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G1
Donazzan, M; Ferri, F; Rose, C; Tellion, C1
Brière, S; Brun-Buisson, C; Petit, C; Schweich, H; Sollet, JP1
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Böhme, C; Hess, U; Rey, K; Senn, HJ1
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N1
Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G1
Martínek, J; Melenovsky, V; Morávek, J; Spicák, J; Závada, F1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P1
Elhelali, N; Jacolot, A; Laurent, F; Léotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K1
Kamiya, A; Mizuno, H; Oie, S; Sawa, A1
Hosino, K; Iwai, Y; Nakamura, A; Nakamura, S; O'Hara, K; Sawai, T; Seto, I1
Minami, S; Ogake, N; Takahata, M; Yamashiro, Y1
Carbon, C; Carlet, J; Dupont, H1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I1
Burgess, DS; Hastings, RW1
O'Connell, M; Petros, AJ; Roberts, C; van Saene, HK; Wade, P1
Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E1
Alvarez-Lerma, F; Barcenilla, F; Insausti-Ordeñana, J; Jordá-Marcos, R; Maraví-Poma, E; Martínez-Pellús, A; Nava, J; Palomar, M; Torres-Martí, A1
Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D1
Minami, S; Takahata, M; Yamada, H1
Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L1
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K1
Chen, TP; Chen, YH; Lu, PL; Peng, CF; Tsai, JJ1
Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L1
Abe, M; Araki, M; Horimi, T; Nasu, Y; Ono, N; Takahashi, I1
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M1
Ashkenazi, S; Bishara, J; Lev, B; Levy, I; Livne, G; Ofir, O; Pitlik, S; Samra, Z1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C1
Flidel-Rimon, O; Friedman, S; Leibovitz, E; Shinwell, ES1
Borzsei, L; Horváth, A; Kocsis, B; Koós, Z; Mintál, T; Nyárády, J1
Aydogdu, I; Ersoy, Y; Kaya, E; Kuku, I; Serefhanoglu, K; Serefhanoglu, S1
Chan, E; Duan, W; Srikumar, S; Zhou, S1
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T1
Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A1
Doi, M; Fujiue, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y; Yano, S1
Alexaki, P; Christakis, GB; Megalakaki, A; Perlorentzou, S; Zarkadis, IK1
Alexaki, P; Alivizatos, AS; Athanasiou, AE; Chalkiopoulou, I; Christakis, GB; Zarkadis, IK1
Fiorentini, A; Ora, J; Paris, A; Perciaccante, A; Serra, P1
Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM1
Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I1
Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A1
Nakwa, F; Velaphi, S; Wadula, J1
Baudrand, H; Devouassoux, G; Freymond, N; Marcu, M; Mbatchou Ngahane, BH; Pacheco, Y1
Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N1
Alvarez Tundidor, S; González Rozas, M; Pineda Alonso, M1
Kılıç, SC; Sarper, N; Zengin, E1
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V1
Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M1
Bernusset, S; Cattoen, C; Cuzon, G; Naas, T; Nordmann, P1
Berthelot, P; Carricajo, A; Lucht, F; Suy, F1
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW1
Chhibber, S; Harjai, K; Singla, S1
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B1
Ben-Shimol, S; Fruchtman, Y; Greenberg, D; Hazan, G; Kapelushnik, J; Leibson, T1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C1
Fukushima, S; Matsumoto, T; Mizuno, Y; Nakamura, I; Sato, A; Tsukimori, A; Yamaguchi, T1
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M1
Jain, N; Tewari, VV1
Ali, N; Baqir, M; Hamid, A; Khurshid, M1
Bhat Y, R; Lewis, LE; Patra, S; Purakayastha, J; Sivaramaraju, VV1
Garg, A; Goel, A; Nangia, S; Randhawa, VS; Saili, A; Sharma, S1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S1
Emiroğlu, M; Köksal, Y; Köse, D1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH1
Grushnikov, A; Iino, R; Kikuchi, K; Matsumoto, Y; Nishino, K; Noji, H; Sakakihara, S; Yagi, Y; Yamaguchi, A1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ1
Choudhary, S; Makwana, M; Soni, JP; Tripathi, N1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Chaudhury, A; Kalawat, U; Rani, AS; Sumant, S; Venkataramana, B; Verma, A1
Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A1
Gao, L; Li, Y; Lyu, Y1
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N1
Li, B; Li, L; Peters, BM; Shirtliff, ME; Xie, J; Xu, Z; Yu, G1
Borgatta, B; Gattarello, S; Imbiscuso, AT; Larrosa, MN; Lujàn, M; Mazo, CA; Rello, J1
Arnaud, E; Larcher, R; Lavigne, JP; Pantel, A; Sotto, A1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK1
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A1
Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D1
Charoenkwan, P; Choeyprasert, W; Fanhchaksai, K; Kamonrattana, R; Natesirinilkul, R; Sathitsamitphong, L1
Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN1
Güler, N; Süleyman, A; Tamay, Z1
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I1
Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J1
Chen, WT; DeRyke, CA; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K1

Reviews

2 review(s) available for piperacillin and amikacin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Respiratory infections: clinical evaluation.
    Clinical therapeutics, 1985, Volume: 7 Suppl A

    Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin

1985

Trials

52 trial(s) available for piperacillin and amikacin

ArticleYear
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients.
    Lancet (London, England), 1992, May-02, Volume: 339, Issue:8801

    Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cloxacillin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Neutropenia; Ofloxacin; Piperacillin; Prospective Studies

1992
Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:2

    Topics: 4-Quinolones; Amikacin; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Male; Neutropenia; Piperacillin; Prospective Studies; Teicoplanin

1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin

1992
[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Piperacillin; Prospective Studies

1992
[Therapeutic trials in pulmonary diseases].
    Presse medicale (Paris, France : 1983), 1991, Mar-23, Volume: 20, Issue:11

    Topics: Amikacin; Drug Evaluation; Drug Therapy, Combination; Humans; Lung Diseases, Parasitic; Piperacillin

1991
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies

1991
Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Adult; Aged; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Penicillins; Piperacillin

1991
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies

1991
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin

1990
Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Aspergillosis; Aspergillus fumigatus; Ceftazidime; Cell Count; Drug Therapy, Combination; Female; Fever; Humans; Male; Piperacillin; Sepsis

1990
Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:3

    Topics: Amikacin; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Infant, Premature, Diseases; Piperacillin; Random Allocation; Risk Factors; Sepsis

1989
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
    Acta clinica Belgica, 1989, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation

1989
[Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Pilot Projects; Piperacillin

1986
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation

1988
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies

1988
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:6

    Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Random Allocation

1987
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Scandinavian journal of infectious diseases. Supplementum, 1987, Volume: 52

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins

1987
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:3 Pt 1

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation

1987
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation

1986
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
    Archives of internal medicine, 1982, Volume: 142, Issue:9

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Penicillins; Piperacillin; Prospective Studies

1982
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    The American journal of medicine, 1981, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin

1981
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:2

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin

1982
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies

1995
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
    Presse medicale (Paris, France : 1983), 1995, Feb-25, Volume: 24, Issue:8

    Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam

1995
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam

1994
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin

1993
Population pharmacokinetic study of teicoplanin in severely neutropenic patients.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Adult; Aged; Amikacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Piperacillin; Staphylococcal Infections; Teicoplanin

1996
Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Consumer Product Safety; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Population; Treatment Failure; Ventilators, Mechanical

1998
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome

1998
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin

1999
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:8

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Tazobactam; Treatment Outcome

2000
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
    Annals of surgical oncology, 2001, Volume: 8, Issue:2

    Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam

2001
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Intensive care medicine, 2001, Volume: 27, Issue:3

    Topics: Aged; Amikacin; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Proportional Hazards Models; Prospective Studies; Spain; Survival Analysis; Treatment Outcome

2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Oct-15, Volume: 33, Issue:8

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome

2001
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2002
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Pediatric hematology and oncology, 2004, Volume: 21, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins

2004
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome

2005
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Current medical research and opinion, 2005, Volume: 21, Issue:5

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome

2005
Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia.
    Annals of the Academy of Medicine, Singapore, 2006, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Assessment; Risk Factors; Tazobactam; Thienamycins

2006
Management of diabetic foot in a Jordanian hospital.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2005, Volume: 11, Issue:3

    Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection

2005
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Singapore medical journal, 2008, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2008
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Pediatric hematology and oncology, 2008, Volume: 25, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2008
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult

2010
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult

2010
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Pediatric hematology and oncology, 2011, Volume: 28, Issue:4

    Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult

2011
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
    Clinical biochemistry, 2012, Volume: 45, Issue:10-11

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome

2012
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Pediatric hematology and oncology, 2013, Volume: 30, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam

2013
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
    Journal of tropical pediatrics, 2014, Volume: 60, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome

2014
Febrile neutropenia: median door-to-needle time - results of an initial audit.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult

2015
Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
    European journal of pediatrics, 2015, Volume: 174, Issue:2

    Topics: Amikacin; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Meconium; Meconium Aspiration Syndrome; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Prospective Studies; Sepsis

2015
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Male; Neoplasms; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome

2019

Other Studies

183 other study(ies) available for piperacillin and amikacin

ArticleYear
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests

2007
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2007
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests

2007
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Endemic Diseases; Female; Gastrointestinal Tract; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Pharynx; Pseudomonas aeruginosa; Pseudomonas Infections; Rectum; Risk Factors

2007
blaVIM-2-harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3' conserved sequence.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Evolution, Molecular; Genes, Bacterial; Humans; India; Integrons; Molecular Sequence Data; Pseudomonas aeruginosa; Russia; United States

2007
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome

2007
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland

2007
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic

2007
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology

2007
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins

2007
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
    Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship

2007
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid

2007
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain

2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance

2008
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Jun-01, Volume: 18, Issue:11

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Combinatorial Chemistry Techniques; Diamines; Escherichia coli; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Protein Biosynthesis; Pseudomonas aeruginosa; Structure-Activity Relationship

2008
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Mexico; Models, Genetic; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections

2008
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Quinolones

2008
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Tigecycline

2008
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids

2008
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones

2008
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Integrons; Italy; Molecular Epidemiology; Molecular Sequence Data

2008
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Enterobacter cloacae; Female; Humans; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Pseudomonas putida; RNA, Ribosomal, 16S

2009
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia

2009
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence

2009
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic

2009
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping

2009
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction

2009
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA

2009
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2009
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Fluoroquinolones; Humans; Travel

2009
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand

2009
Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Ceftazidime; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones

2009
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland

2009
Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Microbial Sensitivity Tests; Polymerase Chain Reaction

2009
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom

2009
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11

    Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa

2009
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins

2009
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure

2009
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan

2010
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors

2010
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Polymerase Chain Reaction

2010
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan

2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare

2010
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests

2010
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Drug Resistance, Bacterial; Germany; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Klebsiella pneumoniae; Models, Genetic; Molecular Sequence Data; Plasmids

2010
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; France; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections

2010
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa

2010
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation

2010
Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Molecular Sequence Data; Plasmids; Taiwan

2010
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
    Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

    Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship

2017
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    European journal of medicinal chemistry, 2019, Apr-15, Volume: 168

    Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline

2019
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    Antimicrobial agents and chemotherapy, 1978, Volume: 13, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae; Escherichia coli; Klebsiella; Penicillin Resistance; Piperacillin; Proteus; Pseudomonas aeruginosa; Serratia

1978
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Scandinavian journal of infectious diseases. Supplementum, 1992, Volume: 81

    Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin

1992
Activity of antibiotics against resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa

1992
[Protective effect by piperacillin against renal impairment caused by amikacin].
    Nihon Jinzo Gakkai shi, 1992, Volume: 34, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Piperacillin

1992
[Common pathogens in burn infection and changes in their drug sensitivity].
    Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns, 1991, Volume: 7, Issue:2

    Topics: Amikacin; Burns; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Proteus; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus

1991
Isolation of Agrobacterium radiobacter from a central venous catheter.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:5

    Topics: Amikacin; Catheterization, Central Venous; Catheters, Indwelling; Equipment Contamination; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Piperacillin; Rhizobium; Sepsis

1991
[In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics].
    Mikrobiyoloji bulteni, 1991, Volume: 25, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Ofloxacin; Piperacillin; Proteus; Pseudomonas; Turkey; Urinary Tract Infections

1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1

    Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins

1991
Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Piperacillin; Streptococcal Infections

1991
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin

1991
One shot of high-dose amikacin: a working hypothesis.
    Chemotherapy, 1990, Volume: 36, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli; Piperacillin; Pseudomonas aeruginosa; Time Factors

1990
[Piperacillin-amikacin combinations: killing curves].
    Pathologie-biologie, 1990, Volume: 38, Issue:7

    Topics: Amikacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter; Escherichia coli; In Vitro Techniques; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa

1990
[Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:9

    Topics: Amikacin; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa

1990
The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74

    Topics: Amikacin; Drug Interactions; Drug Therapy, Combination; Escherichia coli; Humans; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens

1990
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74

    Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus

1990
[The results of antibiotic therapy in acute severe pneumonia dependent on the initial severity].
    Presse medicale (Paris, France : 1983), 1990, Dec-08, Volume: 19, Issue:42

    Topics: Acute Disease; Amikacin; Bacterial Infections; Drug Combinations; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia; Prognosis

1990
[Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
    Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:4

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Escherichia coli; Humans; Klebsiella; Netilmicin; Piperacillin; Proteus; Pseudomonas; Staphylococcus

1989
Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:7

    Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Ceftazidime; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Time Factors

1989
Tolerance of axenically cultured Entamoeba histolytica and Giardia lamblia to a variety of antimicrobial agents.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1985, Volume: 79, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Synergism; Entamoeba histolytica; Giardia; Penicillin Resistance; Piperacillin

1985
[Bactericidal effect of piperacillin alone and combined].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Microbial Sensitivity Tests; Piperacillin

1986
[Enzymologic aspect of piperacillin combinations].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Enterobacter; Enzyme Induction; Hydrolysis; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa

1986
Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:1

    Topics: Adult; Amikacin; Drug Evaluation; Drug Synergism; Escherichia coli; Female; Humans; Kanamycin; Klebsiella pneumoniae; Male; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa

1986
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin

1986
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1986
In vitro activity of BRL 36650, a new penicillin.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas aeruginosa

1986
Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
    Methods and findings in experimental and clinical pharmacology, 1986, Volume: 8, Issue:6

    Topics: Amikacin; Carbenicillin; Cefoperazone; Gentamicins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin

1986
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin

1987
Stability of ampicillin, piperacillin, cefotaxime, netilmicin and amikacin in an L-amino acid solution prepared for total parenteral nutrition of newborn infants.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1988, Volume: 96, Issue:4

    Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Drug Stability; Electrolytes; Glucose; Humans; Infant, Newborn; Netilmicin; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Piperacillin; Solutions; Temperature; Time Factors

1988
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin

1988
Interaction between piperacillin and pefloxacin or amikacin on the selection of resistant mutants of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:5

    Topics: Amikacin; beta-Lactamases; Drug Interactions; Microbial Sensitivity Tests; Mutation; Pefloxacin; Phenotype; Piperacillin; Pseudomonas aeruginosa; Selection, Genetic

1988
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
    Australian and New Zealand journal of medicine, 1988, Volume: 18, Issue:6

    Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin

1988
[Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1986, Volume: 27, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blast Crisis; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Piperacillin

1986
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
    Chemotherapy, 1985, Volume: 31, Issue:3

    Topics: Amikacin; Aminoglycosides; Anaerobiosis; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Salmonella; Serratia; Staphylococcus; Streptococcus; Tobramycin

1985
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis

1985
Malignant external otitis in a diabetic adolescent.
    Journal of adolescent health care : official publication of the Society for Adolescent Medicine, 1986, Volume: 7, Issue:1

    Topics: Adult; Amikacin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Male; Otitis Externa; Piperacillin; Pseudomonas Infections

1986
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
    Medical microbiology and immunology, 1985, Volume: 173, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin

1985
[Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin

1985
[Comparison of the in vitro activity of amikacin, netilmicin, piperacillin and moxalactam against Acinetobacter calcoaceticus var. anitratum].
    Medicina clinica, 1985, Nov-16, Volume: 85, Issue:16

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin

1985
Activity of amikacin, gentamicin and Schering 21420 when combined with carbenicillin or piperacillin against Pseudomonas aeruginosa.
    Chemotherapy, 1982, Volume: 28, Issue:4

    Topics: Amikacin; Aminoglycosides; Carbenicillin; Drug Synergism; Gentamicins; Penicillins; Piperacillin; Pseudomonas aeruginosa

1982
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
    Archives of internal medicine, 1982, Oct-25, Volume: 142, Issue:11

    Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin

1982
Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:6

    Topics: Amikacin; Aminoglycosides; Drug Synergism; Enterobacteriaceae; Gentamicins; Kanamycin; Penicillins; Piperacillin

1983
In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    American journal of clinical pathology, 1980, Volume: 74, Issue:3

    Topics: Amikacin; Aminoglycosides; Carbenicillin; Drug Interactions; Gentamicins; Humans; In Vitro Techniques; Penicillins; Piperacillin; Radioimmunoassay; Tobramycin

1980
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin

1980
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Cleveland Clinic quarterly, 1980,Winter, Volume: 47, Issue:4

    Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin

1980
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 217, Issue:2

    Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin

1981
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
    The American journal of medicine, 1984, Volume: 77, Issue:3

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections

1984
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Kanamycin; Penicillin Resistance; Piperacillin; Pseudomonas Infections; Ticarcillin

1984
[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].
    Pathologie-biologie, 1995, Volume: 43, Issue:3

    Topics: Amikacin; Amoxicillin; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; In Vitro Techniques; Netilmicin; Penicillanic Acid; Piperacillin; Tazobactam

1995
In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa

1995
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin

1996
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:9

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin

1996
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
    Hematology and cell therapy, 1997, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam

1997
[Severe diffuse facial cellulitis].
    Revue de stomatologie et de chirurgie maxillo-faciale, 1997, Volume: 98, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Cause of Death; Cellulitis; Child; Drug Therapy, Combination; Face; Female; Forecasting; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Neck; Penicillins; Piperacillin; Premedication; Risk Factors; Treatment Outcome

1997
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:4

    Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E

1998
Carbapenemase-producing Pseudomonas aeruginosa in UK.
    Lancet (London, England), 1998, Aug-15, Volume: 352, Issue:9127

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom

1998
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
    Pathologie-biologie, 1998, Volume: 46, Issue:6

    Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin

1998
[A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance].
    Pathologie-biologie, 1998, Volume: 46, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Penicillins; Phenotype; Piperacillin; Tazobactam

1998
Penetration of antibiotics into the pancreas in rats: an effect of acute necrotizing pancreatitis.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:1

    Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Female; Ofloxacin; Pancreas; Pancreatic Juice; Pancreatitis, Acute Necrotizing; Piperacillin; Rats; Rats, Wistar; Taurocholic Acid; Tissue Distribution

1999
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipenem; Lung; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar

1999
In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1999
[The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Piperacillin; Tobramycin

2000
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin

2000
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin

2000
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2000
Systemic antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric ICU.
    Chest, 2001, Volume: 119, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; Cohort Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Klebsiella; Klebsiella Infections; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2001
[In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2002
In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    The Kaohsiung journal of medical sciences, 2004, Volume: 20, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Taiwan

2004
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    The Japanese journal of antibiotics, 2004, Volume: 57, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin

2004
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Medycyna doswiadczalna i mikrobiologia, 2004, Volume: 56, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin

2004
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    The Israel Medical Association journal : IMAJ, 2005, Volume: 7, Issue:5

    Topics: Adult; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Child; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Humans; In Vitro Techniques; Israel; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Penicillanic Acid; Piperacillin; Prevalence; Tazobactam

2005
The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis

2006
Comparative study of antibiotic-containing polymethylmetacrylate capsules and beads.
    Chemotherapy, 2006, Volume: 52, Issue:1

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Capsules; Clindamycin; Microspheres; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymethyl Methacrylate

2006
Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Pharmaceutical research, 2006, Volume: 23, Issue:4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Synergism; Half-Life; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Survival Analysis

2006
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins

2006
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics].
    Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin

2006
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:2

    Topics: Amikacin; Anti-Infective Agents; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Meropenem; Oxazines; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Urine

2006
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 8

    Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bacteremia; Base Sequence; Catheterization, Central Venous; Cytarabine; Humans; Leukemia, Myeloid; Male; Methylobacteriaceae; Molecular Sequence Data; Neutropenia; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Bacterial; RNA, Ribosomal, 16S; Vidarabine

2006
Primary bacteraemia caused by Rhizobium radiobacter in a patient with solid tumours.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 10

    Topics: Adult; Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bone Neoplasms; Gram-Negative Bacterial Infections; Humans; Hydroxycorticosteroids; Male; Molecular Sequence Data; Osteosarcoma; Piperacillin; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S

2006
A case of pancytopenia and splenomegaly: haematological disease?
    Internal and emergency medicine, 2007, Volume: 2, Issue:3

    Topics: Amikacin; Diagnosis, Differential; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Pancytopenia; Piperacillin; Splenomegaly

2007
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection

2009
Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.
    Annals of tropical paediatrics, 2009, Volume: 29, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cohort Studies; Drug Administration Schedule; Female; Humans; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Regression Analysis; Retrospective Studies; Risk Factors; Survival Analysis; Thienamycins

2009
[Lung abscess due to community acquired Klebsiella pneumonia].
    Revue des maladies respiratoires, 2009, Volume: 26, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Community-Acquired Infections; Comorbidity; Diabetes Mellitus; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Male; Middle Aged; Piperacillin; Radiography, Thoracic; Shock, Septic; Tomography, X-Ray Computed; Treatment Outcome

2009
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1

    Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole

2011
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
    The new microbiologica, 2011, Volume: 34, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam

2011
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
    Harefuah, 2010, Volume: 149, Issue:12

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome

2010
First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam

2012
[Misleading improvement of abdominal tuberculosis with amikacin, within 72 hours].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Amikacin; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Drug Resistance, Microbial; Drug Therapy, Combination; Etanercept; Female; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Penicillanic Acid; Peritonitis, Tuberculous; Piperacillin; Piperacillin, Tazobactam Drug Combination; Receptors, Tumor Necrosis Factor; Recurrence; Streptomycin; Time Factors; Tuberculosis, Splenic

2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections

2012
Susceptibility of different phases of biofilm of Klebsiella pneumoniae to three different antibiotics.
    The Journal of antibiotics, 2013, Volume: 66, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Culture Media; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin; Plankton

2013
[Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Harefuah, 2012, Volume: 151, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Candida; Child; Child, Hospitalized; Child, Preschool; Clinical Protocols; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infant; Israel; Male; Microbial Sensitivity Tests; Neutropenia; Piperacillin; Prevalence; Treatment Outcome

2012
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1

    Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index

2014
Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2014
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2014, Volume: 24

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2014
Cerebral abscess due to Serratia marcescens.
    Indian journal of pediatrics, 2015, Volume: 82, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Drainage; Frontal Lobe; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Long Term Adverse Effects; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Serratia marcescens; Tomography, X-Ray Computed; Treatment Outcome

2015
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts

2015
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma.
    Turkish journal of medical sciences, 2015, Volume: 45, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors

2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2016
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
    Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection

2016
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine

2016
A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Lab-On-A-Chip Devices; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins

2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin

2016
Pneumocephalus in Child Following Bilateral Otomastoiditis and Nasal Septum Infection.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant; Male; Mastoiditis; Nasal Septum; Otitis Media; Penicillanic Acid; Piperacillin; Pneumocephalus; Pseudomonas Infections; Subdural Effusion; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome

2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Antibiotic resistance & pathogen profile in ventilator-associated pneumonia in a tertiary care hospital in India.
    The Indian journal of medical research, 2016, Volume: 144, Issue:3

    Topics: Amikacin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; India; Intensive Care Units; Klebsiella; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas; Staphylococcus aureus; Tertiary Care Centers; Vancomycin-Resistant Enterococci

2016
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
    Nagoya journal of medical science, 2017, Volume: 79, Issue:1

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies

2017
Trends in Drug Resistance of
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2017
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Le infezioni in medicina, 2017, Mar-01, Volume: 25, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin

2017
Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001-2015.
    Microbial pathogenesis, 2017, Volume: 107

    Topics: Amikacin; Anti-Bacterial Agents; Blood; Carbapenems; Ceftazidime; Cephalosporins; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sputum; Urinary Tract

2017
The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:11

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Ventilators, Mechanical

2017
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
    BMC infectious diseases, 2017, 07-06, Volume: 17, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Caenorhabditis elegans; Community-Acquired Infections; Cross Infection; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Virulence

2017
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1

    Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins

2017
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:3

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination

2018
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2018
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
    International microbiology : the official journal of the Spanish Society for Microbiology, 2022, Volume: 25, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors

2022
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Pediatric pulmonology, 2022, Volume: 57, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
    Scientific reports, 2023, 01-09, Volume: 13, Issue:1

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing

2023
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
    Pakistan journal of pharmaceutical sciences, 2023, Volume: 36, Issue:1

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections

2023
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thailand

2023